Novel CCR3-targeted cyclic peptides as potential therapeutic agents for age-related macular degeneration via inhibiting angiogenesis and reducing retinal photoreceptor damage.
- DOI
- 10.1016/j.bioorg.2024.107405
- Published
- 2024 Jun
- Container
- Bioorganic chemistry
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bioorg.2024.107405,
title = {Novel CCR3-targeted cyclic peptides as potential therapeutic agents for age-related macular degeneration via inhibiting angiogenesis and reducing retinal photoreceptor damage.},
author = {Li Y and Guo S and Wu X and Wan J and Guan Y and Luo C and Chen Q and Jiang H and Lin H and Qian H and Shi W and Fan W},
year = {2024},
journal = {Bioorganic chemistry},
doi = {10.1016/j.bioorg.2024.107405},
url = {https://doi.org/10.1016/j.bioorg.2024.107405}
}RIS
TY - JOUR TI - Novel CCR3-targeted cyclic peptides as potential therapeutic agents for age-related macular degeneration via inhibiting angiogenesis and reducing retinal photoreceptor damage. AU - Li Y AU - Guo S AU - Wu X AU - Wan J AU - Guan Y AU - Luo C AU - Chen Q AU - Jiang H AU - Lin H AU - Qian H AU - Shi W AU - Fan W PY - 2024 JO - Bioorganic chemistry DO - 10.1016/j.bioorg.2024.107405 UR - https://doi.org/10.1016/j.bioorg.2024.107405 ER -
APA
Y, L., S, G., X, W., J, W., Y, G., C, L., Q, C., H, J., H, L., H, Q., W, S., & W, F. (2024). Novel CCR3-targeted cyclic peptides as potential therapeutic agents for age-related macular degeneration via inhibiting angiogenesis and reducing retinal photoreceptor damage.. Bioorganic chemistry. https://doi.org/10.1016/j.bioorg.2024.107405
Source records
- pubmed · retrieved 2026-09-26T17:32:22.508Z